drug · antibody
patient view →vedolizumab
Phase 3updated 2mo agoby $TAK TAKEDA PHARMACEUTICAL CO LTD🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for ulcerative colitis and crohn's disease and 8 investigational indications.
indications
indications
IBD (Crohn's + UC)
targets
Integrin alpha-4/beta-7
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that